Deutsche Bank upgraded shares of (MKGAY) (OTCMKTS:MKGAY) from a hold rating to a buy rating in a report released on Monday morning, The Fly reports.
Separately, Bank of America raised (MKGAY) from a neutral rating to a buy rating in a research report on Tuesday, September 8th.
Shares of (MKGAY) stock opened at $38.36 on Monday. (MKGAY) has a 52-week low of $32.53 and a 52-week high of $42.02.
Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, Performance Materials and Corporate & Other. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility.
Further Reading: What Is An Exchange-Traded Fund (ETF)?
Receive News & Ratings for (MKGAY) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for (MKGAY) and related companies with MarketBeat.com's FREE daily email newsletter.